Filtered by:
17 Programs
-
Second Opinion
Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
-
-
D
-
E
-
F
- +2
-
D
-
-
Second Opinion
Optimal Management of Localized Renal Cell Carcinoma
-
-
E
-
T
-
U
-
E
-
-
Oncology Today
Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer
-
-
W
-
W
-
-
W
-
W
-